Drug intelligence / Profile preview

Ganmao Capsules

Development stage: Unknown
Lead developer: Hebei Wanbang Fu Lin Pharmaceutical
Administration: Oral

Overview

Ganmao Capsules is a traditional Chinese medicine (TCM) formulation manufactured by Hebei Wanbang Fu Lin Pharmaceutical. It is an oral capsule indicated for the symptomatic relief of the common cold and upper respiratory tract infections. As a TCM product, it typically comprises a blend of multiple herbal ingredients—such as Notopterygium incisum, Schizonepeta tenuifolia, and Isatis indigotica—designed to dispel wind, resolve the exterior, and alleviate symptoms including fever, headache, nasal congestion, and cough. It is a marketed product in China and follows traditional pharmacological principles rather than a single-target molecular mechanism.

Brand names: Ganmao Capsules
Other names: 感冒胶囊Ganmao Jiaonang

Beyond the preview

Go deeper on Ganmao Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganmao Capsules.

Explore the full profile